Retrospective Real-Life Study From One Brazilian Reference Center Assessing Long-Term Experience In The Treatment Of Adult Spasticity With AbobotulinumtoxinA (RETURN)

Ipsen

Status: Completed

Conditions: Spasticity

Study type: Observational

Funder types: Industry

Identifiers

NCT04446702

A-BR-52120-269

Details and patient eligibility

About

The aim of the study is to describe the long-term use of abobotulinumtoxinA (Dysport®) in adult subjects affected with upper limb spasticity (ULS) +/- lower limb spasticity (LLS) who received treatment with Dysport® for a minimum of three injections cycles at the Instituto de Medicina Física e Reabilitação do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (IMREA HC FMUSP) in Brazil.

Enrollment: 200 patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Adult aged ≥18 years old at the time of the first Dysport® injection
• Diagnosed with spasticity
• Treated with a minimum of three Dysport® injection cycles for ULS +/- LLS in the observational period
• Follow up effectiveness data are available in the subject's medical record

Exclusion criteria

• Patients have received previous treatment with another BoNT-A less than 12 weeks prior to the patient data collection in the study
• Adults with cerebral palsy
• Patients treated with BoNT-A in a clinical trial setting